Sequella teams up with PATH & US Agency for International Development on TB (tuberculosis) diagnostic
This article was originally published in Clinica
Executive Summary
The start-up company Sequella says it will partner with PATH, a prominent international healthcare non-profit company, in testing the effectiveness of the company's novel tuberculosis diagnostic.